GnRH-agonist implantation of prepubertal male cats affects their reproductive performance and testicular LH receptor and FSH receptor expression by Mehl, N S et al.
  
RVC OPEN ACCESS REPOSITORY – COPYRIGHT NOTICE 
 
This is the peer-reviewed, manuscript version of the following article: 
Mehl, N. S., Khalid, M., Srisuwatanasagul, S., Swangchan-uthai, T. and Sirivaidyapong, S. (2016) 
'GnRH-agonist implantation of prepubertal male cats affects their reproductive performance and 
testicular LH receptor and FSH receptor expression', Theriogenology, 85(5), 841-848. 
The final version is available online via 
http://dx.doi.org/10.1016/j.theriogenology.2015.10.031.            
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/. 
The full details of the published version of the article are as follows: 
 
TITLE: Prognostic factors for 1-week survival in dogs diagnosed with meningoencephalitis of 
unknown aetiology 
AUTHORS: N.S. Mehl, M. Khalid, S. Srisuwatanasagul, T. Swangchan-uthai, S. 
Sirivaidyapong  
JOURNAL TITLE: Theriogenology 
VOLUME/EDITION: 85/5 
PUBLISHER: Elsevier 
PUBLICATION DATE: 15 March 2016 (online) 
DOI: 10.1016/j.theriogenology.2015.10.031 
GnRH-agonist implantation of pre-pubertal male cats affects their reproductive 1 
performance and testicular LHR and FSHR expression 2 
 3 
 4 
 5 
N.S. Mehla, M. Khalidb, S. Srisuwatanasagulc, T. Swangchan-uthaia, S. Sirivaidyaponga* 6 
a Department of Obstetrics, Gynaecology and Reproduction, Faculty of Veterinary Science, Chulalongkorn 7 
University, Bangkok, Thailand. 8 
b Department of Production and Population Health, The Royal Veterinary College, Hertfordshire, The United 9 
Kingdom.  10 
c Department of Anatomy, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand. 11 
 12 
 13 
 14 
*Corresponding author: S.Sirivaidyapong, Tel: +662 2189776, Email: sudson.s@chula.ac.th  15 
16 
Abstract 17 
This study was conducted to investigate the effect of GnRH-agonist implantation in 18 
pre-pubertal tomcats on sexual behavior, reproductive performance and expression of 19 
testicular LHR and FSHR, and also to compare the testicular characteristics, LHR and FSHR 20 
expression between pre-pubertal and adult tomcats. In Exp1, 3 months-old tomcats 21 
(n=6/group) were either treated with or left without 4.7 mg Deslorelin implants. Semen 22 
collection and evaluation were performed just before castration at 48 wks after treatment; 23 
removed testes were analyzed for mRNA and protein expression of LHR and FSHR. We 24 
were able to collect semen from six non-treated cats, whereas in treated cats, semen was 25 
uncollectable. The results revealed that sexual behavior was absent in the implanted cats 26 
throughout the study period. Testicular volume was decreased found from 30 wks after 27 
treatment onwards in the implanted cats compared to the controls (P < 0.05). Semen 28 
production was found only in non-implanted cats. Testicular tissue score, seminiferous tubule 29 
diameter and LHR protein expression was found lower in the implanted cats (P < 0.05) but no 30 
differences were observed in mRNA expression of LHR and protein expression of FSHR 31 
between groups. The mRNA expression of FSHR was higher in the implanted (P < 0.05) 32 
compared to control cats. In Exp2, testes from pre-pubertal (n=6) and adult (n=6) male cats 33 
were collected after castration and analyzed for mRNA and protein expression of LHR and 34 
FSHR. No differences were observed in the protein expression of LHR and FSHR between 35 
the two groups, while mRNA expression of FSHR was higher in pre-pubertal cats (P < 0.05). 36 
Testicular and epididymal weight, diameter of seminiferous tubules and the testicular grade 37 
were higher in the adult compared to pre-pubertal cats (P < 0.05). In conclusion, deslorelin 38 
implants suppressed protein expression of LHR and enhanced mRNA expression of FSHR 39 
along with suppression of reproductive function without any adverse effects for at least 48 40 
wks in male cats. 41 
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Introduction 44 
 Overpopulation of cats is a serious global problem and in big towns/cities roaming of 45 
tomcats is reported to be out of owners’ control. The result is unwanted pregnancies with 46 
undesirable consequences in this species. Free roaming cats without any care are also 47 
subjected to higher risks like suffering from diseases (including zoonotic diseases), 48 
malnutrition and accidents. The number of cats euthanized in shelters is also on the rise every 49 
year mainly due to overpopulation [1] which needs to be controlled in order to address the 50 
welfare problems associated with it.  51 
Contraception is one of the most successful methods for population control in many 52 
animal species. Traditional way of contraception by castration is presently in practice in cats 53 
as well. However, castration is an invasive surgical procedure and can only be performed on 54 
anesthetized animals, whereas anesthesia poses serious problems in juvenile and senile cats 55 
and in cats with health problems. Cats reach puberty by the age of 4 month [2] with a 56 
possibility of mating soon after.  However, surgical neutering in early age may pose risks like 57 
higher sensitivity to many drugs including the anesthetics [3]. Therefore, nonsurgical 58 
neutering could be a welfare-friendly and viable alternative to surgical methods of neutering 59 
[4].  60 
Reproduction in mammals is controlled by the hypothalamic-pituitary-gonadal (HPG) 61 
axis and it has been shown that long-term continuous administration of GnRH 62 
desensitizes/downregulates the pituitary gland, profoundly suppresses the gonadotrophins 63 
release and impairs the reproductive function [5].  Accordingly, a contraceptive method has 64 
been developed; it is employed by GnRH-agonist implantation (Suprelorin®; Peptech Animal 65 
Health), and has been proven effective in pubertal tomcats [5, 6] and female domestic cats [6-66 
8]. This method results into long-term reversible contraception without any negative effects 67 
to the animals. The contraceptive effects of GnRH-agonist have also been reported in other 68 
species such as dogs, wild felids, gilts, flying fox and giraffes [9-15]. Moreover, Trigg, Doyle 69 
[16] have reported that when 4 months old female pups were implanted with  9.4 mg of 70 
deslorelin, contraceptive effect was prolonged and lasted for at least 36 wks while the 71 
contraceptive effect in pubertal dogs was varied from 24 to 48 wks. It is a possibility that this 72 
longevity effect might have been achieved by a delay in the age of puberty in these animals. 73 
Moreover, there are reports to suggest that early-age neutering could reduce undesirable 74 
behaviour of cats especially in adopted cats and could help reduce the unwanted litters in 75 
many pet shelters. Although GnRH implantation has been used in cats to suppress the 76 
reproductive function but the studies in pre-pubertal cats are rare and with variable results 77 
[17, 18].  78 
The effects of GnRH implantation on the gonadotrophins’ release along with the 79 
suppression of reproductive function are well documented [5, 19].  However, it is not known 80 
whether such effects are achieved through an alteration in the gonadal expression of receptors 81 
for LH and FSH and/or  testosterone production.  The present study was, therefore, designed 82 
to investigate the effects of long-term GnRH implantation [4.7 mg GnRH-agonist 83 
(Deslorelin)] on the reproductive performance, testicular morphology and expression of LHR 84 
and FSHR in pre-pubertal male cats.  Testicular morphology and expression of LHR and 85 
FSHR were also compared between pre-pubertal and adult male cats.  86 
 87 
2. Materials and methods 88 
2.1 Experiment design and animals 89 
Experiment 1:  Three months old tomcats that were proven to be clinically healthy and 90 
had attended a complete vaccination program were either implanted with 4.7 mg deslorelin 91 
GnRH-agonist (Suprelorin® 4.7mg, Virbac Animal Health, France) in the interscapular area 92 
(Deslorelin implanted; n=6) or left without any implantation and served as controls (Non-93 
implanted; n=6). The cats were housed together in an open-air room with natural daylight in 94 
the Department of Obstetrics, Gynaecology and Reproduction, Faculty of Veterinary Science, 95 
Chulalongkorn University, Thailand.  During the study period animals were fed with a 96 
commercial diet twice daily with water always available ad libitum. The study had ethical 97 
approval and was performed under the license of Chulalongkorn University Laboratory 98 
Animal Center number13310056.  99 
Implanted animals were monitored for any potential adverse effects like tissue reaction at 100 
the implantation site and/or infection, rashes, oedema, erythema of implantation area etc for a 101 
period of one week. Body temperature was measured daily for one week after the hormonal 102 
implantation to monitor any infection and if found, blood was collected for profile 103 
monitoring.  104 
Body weight of all the cats in both the groups was recorded fortnightly until the end of 105 
the experiment (48 wks) when both the testes were collected after surgical castration. 106 
Throughout the experimental period, functional evaluations of the reproductive organs such 107 
as penile spines, testicular volume and consistency, and male sexual behavioural 108 
characteristics were monitored at 2-weekly intervals in all the cats. Presence of penile spine 109 
was taken as a criterion of puberty [5]. Length, width and depth of the scrotum/testis were 110 
measured using vernier calipers and testicular volume was calculated with a modified 111 
spherical equation; volume (cm3) = 4/3 x π x (1⁄2 length x 1⁄2 width x 1⁄2 depth) [5]. 112 
Testicular consistency was recorded by palpation by one observer and was noted as soft, firm 113 
or hard. Male sexual behaviour such as marking, mounting (with or without intromission), 114 
and fighting [20] were observed for at least 30 min at 2-weekly intervals in all the cats. 115 
Faeces were collected at 2-weekly intervals to measure testosterone concentrations. An 116 
attempt was made to collect semen from all the cats before surgical castration by using the 117 
electro-ejaculator; which was performed 48 wks after implantation. Soon after collection, 118 
semen was evaluated for its volume, colour, motility, concentration, viability and sperm 119 
morphology. If semen ejaculation could not be accomplished, epididymal sperms were 120 
collected immediately after castration and evaluated. 121 
Experiment 2:  Testes were collected from 4 to 6 months old (pre-pubertal, n = 6) or 1 to 122 
3 years old (adult, n=6) normal healthy male cats after surgical castration at the Small Animal 123 
Hospital, Faculty of Veterinary Science, Chulalongkorn University, Thailand.     124 
  In both the experiments, after castration, weight of each testis and epididymis was 125 
recorded. Each testis was divided into two parts; one part was fixed in 4% (w/v) 126 
paraformaldehyde for 48 to 72 hours and then stored in 70% ethanol until processing for 127 
cytology/morphology and immunohistochemistry, whereas the other part was snap frozen in 128 
liquid nitrogen and stored in -80 ºC until RNA extraction. 129 
2.2 Luteinizing hormone receptor (LHR) and Follicle stimulating hormone receptor (FSHR) 130 
Expression 131 
Fixed testicular tissues were embedded in paraffin wax and cut into 5µm sections by a 132 
rotor microtome, applied to gelatin-coated slides and left to dry in an incubator at 37ºC. 133 
Sections were deparaffinized with Xylene (J.T. Baker, PA, USA) and rehydrated through 134 
ascending concentrations of alcohol (50%, 70%, 90%, 99.7% and 100%). The 135 
immunohistochemical staining was performed as described previously by Ponglowhapan et al. 136 
[21]. Briefly, the tissue sections/slides were placed in boiling 0.01M sodium citrate solution, 137 
then cooled down to room temperature for 35 mins to de-mask epitopes. Slides were then rinsed 138 
three times in phosphate buffered saline (PBS). Endogenous peroxidase activity was 139 
inactivated by immersing slides in 1% (v/v) hydrogen peroxide in methanol for 10 min, then 140 
rinsed again three times in PBS. Sections were subsequently blocked for 60 min in a humidified 141 
chamber using a blocking solution, comprising 1% normal horse serum (Vector Laboratories, 142 
CA, USA) diluted in PBS and 20% (v/v) avidin solution (Avidin/Biotin blocking kit; Vector 143 
Laboratories, CA, USA). After washing slides three times in PBS, the slides were incubated 144 
overnight at 4ºC in a humidified chamber with LHR (H–50) polyclonal antibody (Santa Cruz 145 
biotechnology, Inc., USA) at a dilution of 1:50 or with FSHR (N–20) polyclonal antibody 146 
(Santa Cruz biotechnology, Inc., USA) at a dilution of 1:50. The primary antibodies were 147 
diluted in PBS to which 20% (v/v) biotin solution (Avidin/Biotin blocking kit; Vector 148 
Laboratories, CA, USA) was added.  The negative control sections were treated in the same 149 
manner with PBS and biotin mixture in the absence of primary antibodies. After incubation, 150 
sections were washed with PBS three times (3 x 10 minutes). Then, secondary antibody 151 
(Biotinylated anti-mouse anti-rabbit IgG, Vector Laboratories, Inc., USA for LHR localization 152 
and Biotinylated anti-goat IgG, Vector Laboratories, Inc., USA for FSHR localization) were 153 
applied to the sections and incubated for 30 min. Sections were washed again three times in 154 
PBS and incubated at room temperature with 20% (v/v) avidin-biotin complex solution 155 
(VECTASTAIN® Vector Laboratories, Inc., USA) for 30 min. Tissue sections were then 156 
incubated with DAB peroxidase substrate (Vector Laboratories, Inc., USA) until colour 157 
development. All slides were counterstained with Mayer’s hematoxylin. Brown staining was 158 
observed on tissue sections with positive staining for both LHR and FSHR and no staining was 159 
observed for negative controls for either receptor. 160 
At least two sections for both positive antibody staining and negative controls were 161 
examined from each animal.  162 
 163 
2.3 Quantification of immunohistochemical staining 164 
The pattern and intensity of protein staining for LHR and FSHR were determined 165 
semi-quantitatively using a histochemical score (HSCORE) method. Ten fields per 166 
section of each tissue sample were assessed blind by one assessor using a light 167 
microscope at X 200 magnification. The intensity of staining was classified on a scale of 168 
1-3, where 1 = weak staining, 2 = moderate staining and 3 = strong staining [21, 22]. 169 
Histochemical score (H-SCORE) was assessed as percent of each level (weak, moderate 170 
or strong) of staining in each tissue area with the Image-pro plus 7.0 program (Media 171 
Cybernetics, Inc. MD, USA).  An expression index (EI) was calculated for each tissue 172 
sample based on the percentage of positively stained cells and the intensity of staining 173 
using the following formula:  174 
EI = % total stained cells x [(1 x % weak) + (2 x % medium) + (3 x % 175 
strong)]/100  176 
A mean expression index was calculated to represent the protein expression of LHR 177 
or FSHR in each testicular section of every testis from an individual animal [22-24]. 178 
 179 
2.4 Morphology of Testes 180 
Testes collected in both the experiments were fixed, embedded in paraffin wax, cut into 181 
5µm sections and stained with hematoxylin and eosin.  The stained sections (5 sections/testis) 182 
were evaluated for seminiferous tubules; those with normal basement membrane (basement 183 
membrane with a continuous line and germ cells well attached) [19] were considered as normal 184 
and functional. Diameter of seminiferous tubules in each tissue section was measured using 185 
ocular micrometer at X 200 magnification. Using the criteria of Novotny et al. [19] a total of 186 
200 seminiferous tubules per section were classified as st0, st1, st2, st3 and st4 if they had only 187 
spermatogonia (st0), only spermatogonia and spermatocytes (st1), or with spermatids (st2), or 188 
with elongating spermatids (st3) or with elongated spermatids (st4) present in the lumen. Each 189 
tissue section was graded into 5 grades (0 to 4), based on the majority of seminiferous tubules 190 
found in the tissue sections; Grade 0: Testicular tissue with the majority of st0 seminiferous 191 
tubules, Grade 1: Testicular tissue with the majority of st1 seminiferous tubules, Grade 2: 192 
Testicular tissue with the majority of st2 seminiferous tubules, Grade 3: Testicular tissue with 193 
the majority of st3 seminiferous tubules, and Grade 4: Testicular tissue with the majority of st4 194 
seminiferous tubules. Any pathological changes in the testes, if present, were investigated and 195 
recorded. 196 
 197 
2.5 Quantitative real-time polymerase chain reaction (qPCR) for the LHR and FSHR mRNA 198 
in the testicular tissue 199 
2.5.1 Extraction and reverse transcription of mRNA 200 
Frozen testicular tissue was ground with a homogenizer at 10,000 to 20,000 RPM for 10 201 
to 20s and used to extract the total RNA by the RNeasy mini kit (QIAGEN®, Alameda, CA, 202 
USA) following the manufacturer’s instructions. Concentration and purity of the extracted 203 
RNA were assessed by spectrophotometer (ND-2000, NanoDrop,Wilmington, DE, USA). 204 
The RNA samples were stored at -70ºC before qPCR analysis.  205 
2.5.2 Quantitative real-time PCR 206 
Conventional PCR was performed and the PCR product was used for the preparation of 207 
standards and analyzing the optimal melting and annealing temperature for each gene [LHR, 208 
FSHR and GAPDH (reference gene)]. The thermal cycler (G-Storm Thermal Cycler, 209 
Somerset, United Kingdom) was set at the conditions of 15 min at 95ºC to activate Taq DNA 210 
polymerase, 30 cycles of 30s at 94ºC for denaturing, 90s at 57ºC for annealing, 30s at 72ºC 211 
for extension and 10 min at 72º C for the final extension.  Previously published sequences of 212 
forward and reverse primers for feline LHR and FSHR, and GAPDH were used [25, 26] and 213 
are shown in Table 1. Each reaction was contained with Qiagen Multiplex PCR Kit 214 
(QIAGEN®, Alameda, CA, USA). Amplified products were run on 1.2% agarose gel 215 
(SIGMA-ALDRICH®, St, Louis, MO, USA) and visualized under UV gel document and 216 
analysis (SYNGENE® Cambridge, United Kingdom) to confirm the presence of single 217 
products without dimers. Purification of the amplified products was performed with the 218 
QIAquik PCR purification kit (QIAGEN®, Alameda, CA, USA). Purified products were 219 
quantified by spectrophotometer (ND-2000, NanoDrop,Wilmington, DE, USA) and used to 220 
prepare standards for use in qPCR assessment.  221 
Real-time qPCR amplification was performed using CFX96 Thermal cycler (Bio-Rad 222 
Laboratories, Inc., Hercules, CA, USA) with the Bio-Rad CFX manager 3.1 software (Bio-Rad 223 
Laboratories, Inc., Hercules, CA, USA). Each reaction (20µl) was contained with 10µl of 2x 224 
qPCR BIO SyGreen Mix Lo-ROX (PCR Biosystems Ltd, London, United Kingdom), 0.8µl of 225 
each forward and reverse primer, 5µl of a DNA template (5ng/µl), and the volume made up to 226 
20µl with RNase free water. RNase free water was added instead of cDNA template in the 227 
Non-template control (NTC). Thermocycler was set for 38 cycles of denaturing at 95ºC for 5s 228 
following with the optimum annealing temperature of 61.4ºC, 60ºC and 61.4ºC for 25s and 229 
melting temperature of 82ºC, 80ºC and 76ºC for 10s for GAPDH, FSHR and LHR, respectively 230 
with a gradient from 50 to 95ºC to investigate the gene expression. Standards of each gene 231 
were used as controls to determine the absolute quantity of mRNA (fg/μg of total RNA). 232 
2.6 Statistical analysis 233 
Body weight and testicular volume were compared between the deslorelin implanted and 234 
non-implanted (Expt 1) animals using Independent T-test. 235 
General linear model (GLM) was performed to compare the protein and mRNA expression 236 
of LHR and FSHR and the epididymal weight between the deslorelin implanted and non-237 
implanted (Expt 1) and between the pre-pubertal and adult (Expt 2) animals. Wilcoxon rank 238 
sum test was performed to compare the testicular weight, the mean diameter of seminiferous 239 
tubules and the grade of seminiferous tubules between the deslorelin implanted and non-240 
implanted cats (Expt 1) and between the pre-pubertal and adult cats (Expt 2)  241 
3. Results 242 
 No tissue reaction and/or infection were observed after deslorelin implantation.  243 
No difference in body weight was recorded between deslorelin implanted and non-implanted 244 
cats (Figure 1). The implanted cats had significantly lower (P<0.05) testicular volume from wk 245 
30 of study onwards (Figure 2). Male sexual behaviour was absent in implanted cats but was 246 
present in non-implanted cats from 28 wks onwards of the study period.  However, testicular 247 
consistency was soft in both groups and remained soft in deslorelin implanted cats throughout 248 
the study while from the 28th wk until the end of study period non-implanted cats had 249 
comparatively firmer testicular consistency. Penile spines in non-implanted cats were present 250 
from the 28th wk onwards of study period and were absent in implanted cats throughout the 251 
study period of 48 wks. Higher faecal testosterone levels (P<0.05) were observed in non-252 
implanted compared to deslorelin implanted cats from 20 wks onwards of study period (Figure 253 
3). It was possible to collect semen from all of non-implanted cats., semen volume were 10 – 254 
73 μl with 40 – 60% of sperm motility, 49 – 72% of sperm viability and sperm concentration 255 
at 0.15 x 106 – 18 x 106 sperms/ml. Not only implanted cats failed to ejaculate but also we were 256 
not able to collect epididymal sperm from them.  257 
Testicular and epididymal weight, testicular grade and mean seminiferous tubule diameter were 258 
higher in the adult as well as non-implanted cats compared to pre-pubertal or implanted cats (P 259 
< 0.05) (Table 2).  260 
LHR and FSHR were localized in the cytoplasm of Leydig and germ cells, respectively. LHR 261 
expression was significantly higher (p<0.05) in the non-implanted compared to deslorelin 262 
implanted tomcats whereas no difference was found between adult and pre-pubertal animals. 263 
FSHR expression was not different between adult and pre-pubertal cats or between implanted 264 
and non-implanted cats (Figures 4, 5).  265 
LHR and FSHR mRNA were expressed in all the testicular samples collected in both the 266 
experiments.  No differences were observed in the expression of LHR mRNA expression 267 
between the groups in either experiment. The expression of FSHR mRNA, however, was 268 
significantly higher (P < 0.05) in the pre-pubertal and deslorelin implanted cats compared to 269 
adult and non-implanted cats, respectively (Figures 6 and 7). 270 
  271 
4. Discussion 272 
The objectives of this study were to compare 1) the testicular charateristics, and both 273 
protein and mRNA expression of LHR and FSHR between pre-pubertal and adult tomcats and 274 
2) to investigate the effect of GnRH-agonist implantation on the sexual behavior, reproductive 275 
performance and the testicular LHR and FSHR expression in pre-pubertal tomcats.  276 
Deslorelin implantation which was done without any anesthesia, local or general, was 277 
very well tolerated by male pre-pubertal cats as has been reported in previous studies [5, 17]. 278 
The sexual behaviour of implanted cats was suppressed and many unwanted behaviours such 279 
as spraying, fighting and roaming were totally absent in these cats. This suppression of 280 
behaviors resulting from Deslorelin implantation was comparable with behaviours eliminated 281 
by surgical castration [27]. Moreover, suppression of physiology of the reproductive organs 282 
such as, the grade of testicular tissue, the seminiferous tubules diameter, and the weight of 283 
testes and epididymides of implanted cats, which were significantly lower compared to non-284 
implanted cats, confirms the action of Deslorelin implantation on suppressing the function of 285 
male reproductive tract. 286 
The physiology and sexual behavior of male mammals is mainly controlled by 287 
testosterone which is produced by the activation of Leydig cells by the LH released from the 288 
pituitary gland [28, 29]. Aromatase and 5-α reductase transform testosterone into estrogen and 289 
dihydrotestosterone, respectively and these two hormones are considered to be responsible for 290 
the change in the male behaviour.  However, testosterone itself acts on the Sertoli cells of the 291 
testis to support spermatogenesis. FSH is believed to have an important role in the first wave 292 
of spermatogenesis in pre-pubertal mammals but its role in spermatogenesis in adults remains 293 
to be confirmed.  However, FSH is considered to induce meiosis during spermatogenesis 294 
process and therefore, is responsible for increasing the number of spermatogonia in the 295 
seminiferous tubules [30].   296 
The HPG axis is activated by the release of GnRH from the hypothalamus which 297 
stimulates the release of gonadotropins from the pituitary gland to regulate the reproductive 298 
function. The chronic administration of GnRH down regulates the pituitary GnRH receptors 299 
and suppresses the release of gonadotropins and the reproductive function [31]. It is for this 300 
reason that GnRH-agonist implantation is used as an alternative to surgical castration in a 301 
number of species including felines.  In the present study, we have tried to confirm this in pre-302 
pubertal male cats and to explore whether such a GnRH therapy suppresses the reproductive 303 
function via an involvement of testicular expression of LHR and FSHR. FSHR is expressed in 304 
the Sertoli cells of the testes and is responsible to control spermatogenesis after activation by 305 
the FSH [32], whereas  LHR being expressed in the Leydig cells, is responsible to stimulate 306 
androgen secretion [33] by activating the biosynthetic pathway that changes cholesterol into 307 
testosterone [34].  308 
In the present study, the significantly higher expression of FSHR mRNA in the testicular 309 
tissue of deslorelin implanted male cats compared to untreated controls could be a result of the 310 
compensatory mechanism resulting from the suppression of the endogenous release of GnRH 311 
(and/or FSH) due to implantation of deslorelin (GnRH-agonist). It seems that translational 312 
pathway has also been affected by deslorelin implantation as no difference was observed in the 313 
protein expression of FSHR, even though the mRNA expression of the FSHR was significantly 314 
higher in the implanted group. As in pre-pubertal mammals FSH is known to plays a major 315 
role in the first wave of spermatogenesis [30, 35] but in pubertal mammals, spermatogenesis is 316 
mainly androgen-dependent and the effect of FSH is limited mainly to support the production 317 
of spermatogonia [30], the absence of sperm production observed in deslorelin-implanted cats 318 
therefore seems to  result from the suppression of testosterone production due to the 319 
downregulation of LHR in the Leydig cells of deslorelin-treated cats.  320 
In this study, we observed that faecal testosterone concentrations and testosterone-321 
dependent sexual behaviour were both suppressed in deslorelin implanted compared with the 322 
non-implanted cats. We also found that the LHR protein expression in deslorelin implanted 323 
cats was suppressed compared with the non-implanted cats. As testosterone production 324 
depends on the activation of LHR in the Leydig cells, it therefore, seems highly likely that the 325 
observed suppression of faecal testosterone and the testosterone-dependent behaviours may be 326 
the result of observed testicular suppression of LHR protein in the implanted cats.  327 
Both mRNA and protein expression of the LHR were studied in deslorelin-implanted and 328 
control cats.  Deslorelin suppressed the LHR protein expression but was without any effect on 329 
the LHR mRNA. These results suggest that deslorelin downregulates the LHR by interfering 330 
at the translational level but do not interfere transcription of the gene.  Surprisingly, no 331 
difference was observed in the protein or mRNA expression of LHR between the adult and pre-332 
pubertal cats. This may indicate that at the age of 3 months cats already had active Leydig cells 333 
that are capable to produce testosterone. It is difficult to estimate the exact time period after 334 
which deslorelin might have been effective to suppress the LHR in the implanted cats because 335 
the testes were collected only 48 wk after the implantation.  However, there was no difference 336 
in the faecal testosterone concentrations between the two groups at the time of implantation 337 
but from wk20 onwards testosterone concentrations in the implanted group started to be 338 
significantly lower than the controls.  This may suggest that the LHR suppression might have 339 
resulted sometimes within the 20 wks period of deslorelin implantation.  However, it remains 340 
to be determined whether testosterone suppression in deslorelin-implanted cats was the result 341 
of LHR suppression only or was a result of the combined effect of suppression in the LH 342 
concentrations and LHR.  Moreover, this study was not designed to investigate how the 343 
deslorelin implantation directly or indirectly might have affected the biosynthetic pathway of 344 
testosterone production that may involve changes in the cAMP to stimulate the transport of 345 
cholesterol into the mitochondria and changes in the activities of different enzymes responsible 346 
for the pregnenolone, progesterone, androstenone and finally testosterone production [29]. We 347 
speculate that the effect of deslorelin may not be only at the level of LH production and/or 348 
testicular LHR expression but may also be at other sites in the biosynthetic pathway of 349 
testosterone production. A suppression of pulsatile LH secretion from long-term GnRH-agonist 350 
(Goserelin) treatment has already been reported in gilts [15] and several male characteristics 351 
such as the presence of penile spines and male behaviours such as roaming, fighting and 352 
spraying are gonadal steroid hormones (especially testosterone) dependent and could be 353 
eliminated via the suppression of testosterone [27].   354 
Normally GnRH-agonist implantation presents an upregulation effect in the first period 355 
after hormonal implantation followed by a downregulation effect after long-term 356 
administration in pubertal tomcats [5]. However, in this study we did not observe any 357 
upregulation effect when male cats were implanted with GnRH-agonist at the age of 3 months 358 
possibly because of an immature HPG axis at this age [17].  359 
This study was not designed to investigate whether the observed suppression of the 360 
reproductive function could be reversed or not. However, non-reversibility of reproductive 361 
function has been reported in dogs that were implanted with GnRH agonist before the age of 4 362 
months [16, 36]. Reversibility of reproductive function has been reported in studies using 1.6 363 
mg deslorelin in post-natal cats and 4.7 mg deslorelin in 114 days old female cats, puberty was 364 
postponed until the age of 16 months and 134 to 286 days, respectively [17, 18] .  However, in 365 
this study it remains to be seen whether reproductive function could be reinstated or not, 366 
nevertheless, the results obtained show that reproductive function remained suppressed for a 367 
period of at least 48 wks after 4.7 mg deslorelin administration at the age of 3 months.   368 
In conclusion, the results of the present study have shown that implantation of 4.7 mg 369 
GnRH-agonist (Deslorelin®) in male cats at the age of 12 wks suppresses the reproductive 370 
function for at least for 48 wks without any adverse effects on the general health. Moreover, 371 
this suppression of reproductive function may be achieved partly by down-regulation of LHR 372 
in the Leydig cells while maintaining the FSHR expression at the pre-pubertal levels in the 373 
Sertoli cells of the testis. 374 
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485 
Table 1: Description of forward and reverse primers for GAPDH as housekeeping gene and 486 
feline LH receptor (LHR) and FSH receptor (FSHR) as target genes. 487 
Gene Primer sequence (5′–3′) 
Length 
(bp) Reference 
GAPDH 
F: GGAGAAAGCTGCCAAATATG 20 
[25] and 
[26] R: AGGAAATGAGCTTGACAAAGTGG 23 
LHR 
F: CTAATGCCTTTGACAACCTAATA 23 
[25] R: CCCATTGAATGCATGACTTTGTA 23 
FSHR 
F: CATGCTGCTAGGCTGGATCTT 21 
[25] R: CTTGGCGATCTTGGTGTCACT 21 
 488 
 489 
 490 
Table 2: Mean ± SEM values for weight (g) of the testes and epididymides, seminiferous 491 
tubule diameter (μm), and grade of testicular tissues obtained from tomcats in both the 492 
experiments. 493 
Expt Groups 
Weight (g) 
Seminiferous tubule 
diameter (μm) 
Testicular tissue 
grade Testes Epididymides 
1 
Implanted 
0.09 ± 
0.02a 0.03 ± 0.01a 62.02 ± 2.88a 0.00 ± 0.00a 
Non-implanted 
1.54 ± 
0.20b 0.26 ± 0.03b 98.48 ± 3.59b 3.86 ± 0.17b 
2 
Adult 
1.24 ± 
0.20x 0.24 ± 0.03x 95.31 ± 3.94x 3.83 ± 0.41x 
Prepubertal 
0.19 ± 
0.04y 0.08 ± 0.02y 57.85 ± 8.50y 1.33 ± 0.21y 
 494 
Values within a column with different superscript letters (a, b and x, y) in an experiment differ 495 
significantly (P < 0.05).  496 
Figure legends 497 
 498 
Figure 1: The mean (± SEM) body weight (kg) in cats (n=6/group) with or without deslorelin 499 
implantation. Cats were implanted with deslorelin at the age of 3 months for a period of 48 500 
weeks. 501 
  502 
 503 
Figure 2: The mean (± SEM) testicular volume (cm3) in cats (n=6/group) with or without 504 
deslorelin implantation.  Cats were implanted with deslorelin at the age of 3 months for a 505 
period of 48 weeks. Black arrow indicates the week that the control group has significantly 506 
higher (p < 0.05) testicular volume than the implanted group. 507 
  508 
 509 
Figure 3.  The mean (± SEM) faecal testosterone levels (ng/g of faeces) in cats (n=6/group) 510 
with or without deslorelin implantation.  Cats were implanted with deslorelin at the age of 3 511 
months for a period of 48 weeks. Black arrow indicates the week when the control group 512 
started to have significantly higher faecal testosterone levels than the implanted group (P < 513 
0.05). 514 
 515 
  516 
 517 
Figure 4. The mean expression index (± SEM) for LHR and FSHR in testicular tissue of 518 
pubertal and pre-pubertal cats (n=6/group). Different letters on bars for a certain receptor 519 
indicate significant differences (P ≤ 0.05). 520 
  521 
 522 
 523 
 524 
 525 
Figure 5. The mean expression index (± SEM) for LHR and FSHR in testicular tissue of cats 526 
(n=6/group) with or without deslorelin implantation. Cats were implanted with deslorelin at 527 
the age of 3 months for 48 weeks. Different letters on bars for a certain receptor indicate 528 
significant differences (P ≤ 0.05). 529 
  530 
 531 
Figure 6. The mean mRNA concentration (fg/μg mRNA) (± SEM) for LHR and FSHR in 532 
testicular tissue of pubertal and pre-pubertal cats (n=6/group). Different letters on bars for a 533 
certain receptor indicate significant differences (P ≤ 0.05). 534 
  535 
 536 
Figure 7. The mean mRNA concentration (fg/μg mRNA) (± SEM) for LHR and FSHR in 537 
testicular tissue of cats (n=6/group) with or without deslorelin implantation. Cats were 538 
implanted with deslorelin at the age of 3 months for 48 weeks. Different letters on bars for a 539 
certain receptor indicate significant differences (P ≤ 0.05). 540 
 541 
